Lecture 5 Chromatin Inhibitors Flashcards
chromatin inhibitors derived from
plants
Topoisomerases function
enzymes that regulate DNA supercoiling
Two types: type 1 and type 2
How does type 1 topo work
cuts into DNA and makes a nick, DNA relaxes
how does type 2 topo workd
makes 2 cuts at same location, whole genome can be relaxed
Topoisomerase I
changes the degree of supercoiling by causing:
- single strand breaks
- re-ligation (reseals the cut)
Topoisomerase II
causes double strand breaks and then re-ligation
Topoisomerase I inhibitors
camptothecin derivatives:
Topotecan/(hycamtin): advanced ovarian and small cell lung cancer
Irinotecan (CPT-11)/Camptosar: metastatic colon cancer
MOA of camptothecin
bind Topo I and stabilize the complex
inhibitors allow uncoiling of DNA, but prevent subsequent re-ligation -> apoptosis
Irinotecan
activated by liver carboxylesterases to SN-38
colon and rectal cancer
Cell cycle S phase specific
Toxicity topotecan and Irinotecan
Topotecan (renal): acute: N/V; delayed: bone marrow depression
Irinotecan (bile): acute: N/V/D; delayed: severe diarrhea and bone marrow suppression
Topoisomerase II inhibitors
Podophyllotoxin derivaties (etoposide and teniposide)
Mitoxantrone
Anthracyclines
Podophyllotoxin derivatives
block religation reaction of topoisomerase II by a mechanism independent of DNA binding, leading ot the accumulation of protein linked single and double strand DNA breaks (cleavale complexes). Cells in the S and G2 phases of the cell cycle show the greatest sensitivity to these agents
MOA of Topo II inhibitors
Normal topoisomerase II functioning: 1. Topoisomerase II-DNA complex. 2. Double-strand cleavage (transient) 3. Re-ligation. In the presence of drug: (4) Topoisomerase II-DNA complex is stabilized. (5) Irreversible double strand breakage.
Mitoxantrone (novantrone)
- Structurally similar to doxorubicin.
- Cell-cycle phase nonspecific, but most active in the late S phase.
- Produce less quinone type free radicals and cause less cardiac toxicity than doxorubicin (important!)
- For advanced hormone-refractory prostate ca and non-Hodgkin’s lymphoma.
MOA of mitoxantrone
Topoisomerase II inhibition.
Nonintercalative DNA interactions.
DNA intercalation